Bisphosphonates and tumor burden

Journal of Clinical Oncology

Volumn 20, Issue 15, 2002, Pages 3191-3192

  Mundy, Gregory R ^a  

^a CTRC Institute for Drug Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; RISEDRONIC ACID;

ADVANCED CANCER; BONE DENSITY; BONE METASTASIS; BONE MINERAL; BREAST CARCINOMA; CANCER SURVIVAL; CLINICAL TRIAL; DRUG INDICATION; EDITORIAL; HUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; SAMPLE SIZE; TREATMENT OUTCOME;

EID: 0036682310     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.20.15.3191     Document Type: Editorial

References (20)

1. Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer
2. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases
3. Adjuvant clodronate treatment does not reduce the frequency of skeletal metastases in node-positive breast cancer patients: 5-Year results of a randomized controlled trial
4. Reduction in new metastases in breast cancer with adjuvant clodronate treatment
5. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice
6. Oral clodronate and reduction in loss of bone mineral density in women with operable primary breast cancer
7. Adjuvant clodronate reduces the incidence of bone metastases in patients with primary operable breast cancer
8. Scanning electron microscopy in bone pathology: Review of methods, potenial and applications
9. Efficacy of pamidronate in reducing skeletal events in patients with advanced myeloma
10. A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma
11. Overview of bisphosphonates
12. J Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including rats
13. Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates
14. Bisphosphonates act directly on the osteoclast to induce cleavage of mst1 kinase during aptosis: A link between inhibition of the mevalonate pathway and regulation of an apoptosis-promoting kinase
15. Localization of parathyroid hormone-related protein in breast cancer metastases: Increased incidence in bone compared with other sites
16. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis
17. Blockade of TGFβ signaling inhibits parathyroid hormone-related protein (PTH-rP) secretion by breast cancer cells and the development of bone metastasis
18. Overview of bisphosphonates
19. Bisphosphonates induce apoptosis in human myeloma cell lines: A novel anti-tumour activity
20. In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates